Healthcare

Waters Corporation (WAT) Shares Fall 14.5% Following FY2026 Guidance Despite Q4 Beat

Waters Corporation (WAT) shares dropped 14.49% to $326.04 in early trading on Tuesday after the life sciences company issued 2026…

9 hours ago

Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears

Anavex Life Sciences Corp. (NASDAQ: AVXL) continues advancing its innovative CNS pipeline. Anavex Q1 2026 earnings revealed cash position surging…

18 hours ago

BD Posts Solid Q1 Fiscal 2026 Results Ahead of Major Business Pivot

BD (Becton, Dickinson and Company) (NYSE: BDX) reported first-quarter fiscal 2026 results on February 9, 2026, with revenue of $5.3…

22 hours ago

Eli Lilly and Company (LLY) to acquire Orna Therapeutics

Eli Lilly and Company (NYSE: LLY) on Monday said it signed an agreement to acquire Orna Therapeutics, Inc., a biotechnology…

22 hours ago

Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15%

Medical technology company Becton, Dickinson and Company (NYSE: BDX) reported a decline in adjusted earnings for the first quarter of…

23 hours ago

Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook

Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year…

4 days ago

Immunovant Inc (IMVT) Shares Surge 12.4% on Q3 Earnings Beat, Pipeline Milestones

Shares of Immunovant Inc (IMVT) Stock trading near the high end of its 52-week range Shares of Immunovant Inc (IMVT)…

4 days ago

Centene shares slide after fourth-quarter loss and elevated medical costs

Centene Corporation (NYSE: CNC) closed at $39.92, down 2.54% on the day, after reporting fourth-quarter and full-year 2025 results. The…

4 days ago

Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance

Encompass Health Corporation (NYSE: EHC) reported its financial results for the fourth quarter and full year ended December 31, 2025,…

4 days ago

Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7%

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The…

4 days ago